InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,588.30
(
-0.81%
)
US TECH 100
19,671.60
(
-2.22%
)
Dow Jones
39,760.13
(
0.10%
)
Brent Oil
85.09
(
0.04%
)
Bitcoin
57,884.17
(
0.22%
)
Post# of 252572
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120028
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 100551

Tuesday, 08/03/2010 2:16:53 PM

Tuesday, August 03, 2010 2:16:53 PM

Post# of 252572

There will always be a cloud hanging over Momenta until the FDA acts one way or the other on both Teva and Amphastar.

Yes to some degree with respect to Teva, but not with respect to Amphastar because it’s clear that the Amphastar ANDA is not close to being approved. It’s unlikely, IMO, that it ever will be.

Inasmuch as Amphastar is an also-ran company with no known expertise in the characterization of complex mixtures, I fail to see why anyone would think Amphastar has what it takes to meet the requirements laid out in the FDA’s response to SNY’s Citizen Petition.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up